Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230451 · ClinicalTrials.gov registry record · Phase 2
Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma
A Phase 2 study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00230451 is a Phase 2 study that has completed, run by University of Michigan Rogel Cancer Center.
The verdict
NCT00230451, a Phase 2 study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add benefit. The purpose of this study is to determine if a treatment program of combined chemotherapy and radiation therapy prior to surgery and chemotherapy after surgery will delay or eliminate recurrence of the cancer.
Interventions
- DRUG Cisplatin
- DRUG Paclitaxel
- DRUG 5-Fluorouracil
- PROCEDURE Radiation
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-11 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00230451
The ClinicalTrials.gov registry entry for NCT00230451 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Cisplatin is the first listed.
NCT00230451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00230451 about?
NCT00230451 is a clinical study titled "Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma". Surgery (esophagectomy or removal of the esophagus)has been the standard treatment for cancer of the esophagus. However, evidence suggests that preoperative chemotherapy and radiation therapy may add benefit. The purpose of this study is to determine if a treatment program of combined chemotherapy a...
What is the current status of trial NCT00230451?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-11. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00230451?
The interventions under investigation include: Cisplatin (DRUG), Paclitaxel (DRUG), 5-Fluorouracil (DRUG), Radiation (PROCEDURE).
Who is sponsoring clinical trial NCT00230451?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.